Tyrosine kinase inhibitors

Results: 62



#Item
41Bulletin #893  October 3, 2014 NB Drug Plans Formulary Update This update to the New Brunswick Drug Plans Formulary is effective October 3, 2014.

Bulletin #893 October 3, 2014 NB Drug Plans Formulary Update This update to the New Brunswick Drug Plans Formulary is effective October 3, 2014.

Add to Reading List

Source URL: www2.gnb.ca

Language: English - Date: 2014-10-07 09:14:30
42Cancer Therapeutics Program  Kit S. Lam, MD, PhD Professor and Chair Department of Biochemistry & Molecular Medicine

Cancer Therapeutics Program Kit S. Lam, MD, PhD Professor and Chair Department of Biochemistry & Molecular Medicine

Add to Reading List

Source URL: missions.llnl.gov

Language: English - Date: 2011-11-02 16:55:34
43Subject Matter: Lessons from Cancer FROM CANCER TO HIV-1: REPURPOSING KINASE INHIBITORS TO REDUCE HIV-1 INFECTION EX VIVO Stephen McCarthy 1; Darinka Sakac 2; Anton Neschadim 3; Donald Branch 1, 2, 3, 4; 1 Department of

Subject Matter: Lessons from Cancer FROM CANCER TO HIV-1: REPURPOSING KINASE INHIBITORS TO REDUCE HIV-1 INFECTION EX VIVO Stephen McCarthy 1; Darinka Sakac 2; Anton Neschadim 3; Donald Branch 1, 2, 3, 4; 1 Department of

Add to Reading List

Source URL: backtobasic.ohtn.on.ca

Language: English - Date: 2014-11-03 14:04:14
44BP today reiterated its determination to improve performance by simplifying how the company is structured and run, ensuring th

BP today reiterated its determination to improve performance by simplifying how the company is structured and run, ensuring th

Add to Reading List

Source URL: www.gsk.ca

Language: English - Date: 2013-02-06 11:03:20
45Issue 5 “An international scientific symposium for interaction and exchange among basic scientists and clinicians in breast cancer.” Year in Review: 2013 A Pubmed search for articles with the word “cancer” in the

Issue 5 “An international scientific symposium for interaction and exchange among basic scientists and clinicians in breast cancer.” Year in Review: 2013 A Pubmed search for articles with the word “cancer” in the

Add to Reading List

Source URL: www.sabcs.org

Language: English - Date: 2013-12-17 10:26:00
46Molecular Testing Guideline for Selection of Lung Cancer Patients for EGFR and ALK Tyrosine Kinase Inhibitors Summary of Recommendations Section I. When Should Molecular Testing of Lung Cancers Be Performed? Question 1.

Molecular Testing Guideline for Selection of Lung Cancer Patients for EGFR and ALK Tyrosine Kinase Inhibitors Summary of Recommendations Section I. When Should Molecular Testing of Lung Cancers Be Performed? Question 1.

Add to Reading List

Source URL: www.amp.org

Language: English - Date: 2013-04-03 10:57:43
471  Pharmacotherapy JAK inhibitors in myeloproliferative neoplasms

1 Pharmacotherapy JAK inhibitors in myeloproliferative neoplasms

Add to Reading List

Source URL: www.mpnresearchfoundation.org

Language: English - Date: 2011-09-13 08:25:55
48Rx DRUG INTERACTIONS  Drug Interactions with Tyrosine Kinase Inhibitors John R. Horn, PharmD, FCCP, and Philip D. Hansten, PharmD

Rx DRUG INTERACTIONS Drug Interactions with Tyrosine Kinase Inhibitors John R. Horn, PharmD, FCCP, and Philip D. Hansten, PharmD

Add to Reading List

Source URL: www.hanstenandhorn.com

Language: English - Date: 2010-05-03 00:57:13
49Tyrosine Kinase Inhibitors (TKIs) and non-QT cardiotoxicity Reagan-Udall Foundation for the FDA Open Public Meeting May 23, 2013

Tyrosine Kinase Inhibitors (TKIs) and non-QT cardiotoxicity Reagan-Udall Foundation for the FDA Open Public Meeting May 23, 2013

Add to Reading List

Source URL: www.reaganudall.org

Language: English - Date: 2013-05-29 11:08:40
50Angiogenesis and Current Antiangiogenic Strategies for the Treatment of Cancer

Angiogenesis and Current Antiangiogenic Strategies for the Treatment of Cancer

Add to Reading List

Source URL: www.sirweb.org

Language: English - Date: 2010-12-01 15:33:51